Crossmark

Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

Published Online: 2021-12-23

Published Print: 2021-12

Authors

Keiser, Jennifer https://orcid.org/0000-0003-0290-3521
Häberli, Cécile
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_175585)
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-23
More Information

Article History

Received: 14 October 2021

Accepted: 4 December 2021

First Online: 23 December 2021

Declarations

:

: All animal experiments were authorized by the veterinary office from Canton Basel Stadt (authorization no. 2070) based on the Swiss national and cantonal regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current